Market Report · July 22, 2026
Report Feature
The future of the bioabsorbable stent/bioresorbable scaffold market looks promising with opportunities in the hospital and cardiac centers industries. The global bioabsorbable stent/bioresorbable sca
ffold market is expected to grow with a CAGR of 12% from 2019 to 2024. The major growth drivers for this market are high prevalence of cardiovascular diseases, steep increase in the aging population, and the expanding base of the obese population.A report of more than 150 pages is developed to help in your business decisions. Sample figures with some insights are shown below. To learn the scope of, benefits, companies researched and other details of bioabsorbable stent/bioresorbable scaffold market report download the report brochure
The study includes the bioabsorbable stent/bioresorbable scaffold market size and forecast for the global bioabsorbable stent/bioresorbable scaffold market through 2024, segmented by material, absorption rate, application, end user, and region as follows:
By Material [$M shipment analysis for 2013 – 2024]:
- Bioresorbable Polymer Based Stents
- Bioresorbable Metallic Stents
By Absorption Rate [$M shipment analysis for 2013 – 2024]:
- Slow- absorption Stents
- Fast- absorption Stents
By Applications [$M shipment analysis for 2013 – 2024]:
- Coronary Artery Diseases
- Peripheral Artery Diseases
By End User [$M shipment analysis for 2013 – 2024]:
- Hospitals
- Cardiac Centers
By Region [$M shipment analysis for 2013 – 2024]:
-
North America
- United States
- Canada
- Mexico
-
Europe
- United Kingdom
- Germany
- France
- Italy
- Spain
-
Asia Pacific
- China
- India
- Japan
-
Rest of the World
- Brazil
Some of the bioabsorbable stent/bioresorbable scaffold companies profiled in this report include Abbott, REVA Medical, Elixir Medical, KYOTO MEDICAL PLANNING Co., BIOTRONIK, Amaranth Medical, Arterial Remodeling Technologies, Meril Life Sciences, Arterius, LEPU MEDICAL TECHNOLOGY CO., Boston Scientific, 480 Biomedical, S3V Vascular Technologies, Qualimed, and ORBUSNEICH.
Some of the features of this report:
- Market size estimates: Global bioabsorbable stent/bioresorbable scaffold market size estimation in terms of value ($M) shipment.
- Trend and forecast analysis: Market trend (2013-2018) and forecast (2019-2024) by segments and region.
- Segmentation analysis: Global market size by material, absorption rate, application, end user, and region.
- Regional analysis: Global bioabsorbable stent/bioresorbable scaffold market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
- Growth opportunities: Analysis on growth opportunities in different applications and regions for bioabsorbable stent/bioresorbable scaffold in the global bioabsorbable stent/bioresorbable scaffold market.
- Strategic analysis: This includes M&A, new product development, and competitive landscape for, bioabsorbable stent/bioresorbable scaffold in the global bioabsorbable stent/bioresorbable scaffold market.
- Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
Table of Contents
1. Executive Summary 2. Market Background and Classifications 2.1: Introduction, Background, and Classifications 2.2: Supply Chain 2.3: Industry Drivers and Challenges
5. Competitor Analysis 5.1: Product Portfolio Analysis 5.2: Market Share Analysis 5.3: Operational Integration 5.4: Geographical Reach 5.5: Porter’s Five Forces Analysis
7. Company Profiles of Leading Players 7.1: Abbott 7.2: REVA Medical 7.3: Elixir Medical 7.4: KYOTO MEDICAL PLANNING 7.5: BIOTRONIK, Amaranth Medical 7.6: Arterial Remodeling Technologies 7.7: Meril Life Sciences 7.8: Arterius 7.9: LEPU MEDICAL TECHNOLOGY 7.10: Boston Scientific
Methodology
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
- In-depth interviews of the major players in this market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Buy Now
Choose a license that fits your team. Instant PDF delivery.
Prices exclude taxes. Instant delivery. Custom licensing available on request.
Key Questions
- • What are some of the most promising potential, high-growth opportunities for the global bioabsorbable stent/bioresorbable scaffold market by material (bioresorbable polymer based stents and bioresorbable metallic stents), absorption rate (slow- absorption stents and fast- absorption stents), applications (coronary artery diseases and peripheral artery diseases), end user (hospitals and cardiac centers), and region (North America, Europe, Asia-Pacific, and ROW)?
- • Which segments will grow at a faster pace and why?
- • Which regions will grow at a faster pace and why?
- • What are the key factors affecting market dynamics? What are the drivers and challenges of the bioabsorbable stent/bioresorbable scaffold market?
- • What are the business risks and threats to the bioabsorbable stent/bioresorbable scaffold market?
- • What are emerging trends in this bioabsorbable stent/bioresorbable scaffold market and the reasons behind them?
- • What are some changing demands of customers in the bioabsorbable stent/bioresorbable scaffold market?
- • What are the new developments in the bioabsorbable stent/bioresorbable scaffold market? Which companies are leading these developments?
- • Who are the major players in this bioabsorbable stent/bioresorbable scaffold market? What strategic initiatives are being implemented by key players for business growth?
- • What are some of the competitive products and processes in this bioabsorbable stent/bioresorbable scaffold area and how big of a threat do they pose for loss of market share via material or product substitution?
- • What M & A activities have taken place in the last 5 years in bioabsorbable stent/bioresorbable scaffold market?
